Accessibility Menu
 

Is 1 Dose of Pfizer and BioNTech's Vaccine Good Enough?

The booster may not be necessary for short-term coverage, but long-term coverage is still a big unknown.

By Brian Orelli, PhD and Keith Speights Mar 6, 2021 at 11:02AM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.